RT Journal Article
SR Electronic
T1 The COVID-19 pandemic amplified long-standing racial disparities in the United States criminal justice system
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.14.21267199
DO 10.1101/2021.12.14.21267199
A1 Klein, Brennan
A1 Ogbunugafor, C. Brandon
A1 Schafer, Benjamin J.
A1 Bhadricha, Zarana
A1 Kori, Preeti
A1 Sheldon, Jim
A1 Kaza, Nitish
A1 Wang, Emily A.
A1 Eliassi-Rad, Tina
A1 Scarpino, Samuel V.
A1 Hinton, Elizabeth
YR 2022
UL http://medrxiv.org/content/early/2022/01/11/2021.12.14.21267199.abstract
AB During the first year of the COVID-19 pandemic, the number of incarcerated people in the United States decreased by at least 16%—the largest, fastest reduction in prison population in American history. Using an original dataset curated from public sources on prison demographics across all 50 states and the District of Columbia, we show that incarcerated white people benefited disproportionately from this decrease in the U.S. prison population, and the fraction of incarcerated Black and Latino people sharply increased. This pattern deviates from a decade-long trend before 2020 and the onset of COVID-19, during which the proportion of incarcerated Black people was declining. Using case studies of select states, we explore and quantify mechanisms that could explain these disparities: temporary court closures that led to fewer prison admissions, changes in the frequency of police interactions, and state-level prison release policies that sought to de-densify congregate settings. These findings illuminate how systemic inequalities pervade juridicial and penal institutions and are key features of mass incarceration in America.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding. The findings and conclusions in this study are those of the authors and do not necessarily represent the official position of the The Rockefeller Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.